Dezhan Healthcare Company Limited (SHE:000813)
China flag China · Delayed Price · Currency is CNY
3.230
+0.030 (0.94%)
Sep 30, 2026, 3:04 PM CST

Dezhan Healthcare Company Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
372.1396.04465.59496.37570.74729.81
Other Revenue
0.980.770.91.720.114.67
373.09396.81466.49498.09570.86734.48
Revenue Growth
-2.97%-14.94%-6.35%-12.75%-22.28%-23.72%
Cost of Revenue
203.18185.58170.39223.13359.44261.42
Gross Profit
169.91211.23296.09274.96211.41473.06
Selling, General & Admin
287.77300.62293.26263.26303.62342.89
Research & Development
92.0982.2868.3751.151.4967.06
Other Operating Expenses
16.6412.859.2911.479.4612.3
Operating Expenses
399.53393.25376.76330.64364.51423.29
Operating Income
-229.62-182.03-80.67-55.69-153.149.77
Interest Expense
-3.06-2.31-0.37-0.37-0.71-0.65
Interest & Investment Income
40.2717.2266.36148.3286.884.82
Currency Exchange Gain (Loss)
-00-1.87-3.46-0.23
Other Non Operating Income (Expenses)
-55.89-57.04-10.28-10.95-9.94-164.68
EBT Excluding Unusual Items
-248.3-224.16-24.9679.45-80.4-30.97
Impairment of Goodwill
-43.87-43.87----14.2
Gain (Loss) on Sale of Investments
-101.06-109.92-19.87---
Gain (Loss) on Sale of Assets
1.371.38-0.02-0.030.330.02
Asset Writedown
-46.04-45.77-1.56-7.23-41.98-0.31
Other Unusual Items
3.251.922.39.650.988.36
Pretax Income
-434.66-420.42-44.1181.84-121.08-37.11
Income Tax Expense
2.81.5-1.8927.632.3859.09
Earnings From Continuing Operations
-437.46-421.93-42.2254.24-153.46-96.2
Minority Interest in Earnings
76.7776.5121.8129.07106.5138.62
Net Income
-360.69-345.42-20.4183.31-46.95-57.58
Net Income to Common
-360.69-345.42-20.4183.31-46.95-57.58
Net Income Growth
------
Shares Outstanding (Basic)
2,0942,1152,1492,1812,2152,241
Shares Outstanding (Diluted)
2,0942,1152,1492,1812,2152,241
Shares Change
-1.98%-1.56%-1.48%-1.52%-1.15%0.95%
EPS (Basic)
-0.17-0.16-0.010.04-0.02-0.03
EPS (Diluted)
-0.17-0.16-0.010.04-0.02-0.03
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-326.97-231.27-181.14-31.8694.16-84.51
Free Cash Flow Per Share
-0.16-0.11-0.08-0.010.04-0.04
Gross Margin
45.54%53.23%63.47%55.20%37.04%64.41%
Operating Margin
-61.55%-45.87%-17.29%-11.18%-26.82%6.78%
Profit Margin
-96.68%-87.05%-4.38%16.73%-8.22%-7.84%
Free Cash Flow Margin
-87.64%-58.28%-38.83%-6.40%16.50%-11.51%
EBITDA
-148.5-98.450.3125.7-64.27127.85
EBITDA Margin
-39.80%-24.81%0.07%5.16%-11.26%17.41%
D&A For EBITDA
81.1183.5780.9881.3988.8378.08
EBIT
-229.62-182.03-80.67-55.69-153.149.77
EBIT Margin
-61.55%-45.87%-17.29%-11.18%-26.82%6.78%
Effective Tax Rate
---33.72%--
Revenue as Reported
373.09396.81466.49498.09570.86734.48
Advertising Expenses
-44.0846.3552.54108.97148.13